Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides

Vaccine

Volumn 24, Issue 25, 2006, Pages 5381-5389

  Ovsyannikova, Inna G ^a   Vierkant, Robert A ^b   Poland, Gregory A ^a,c  

^a Mayo Vaccine Research Group   (United States)

^b Department of Health Sciences Research ^*  (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cytokines; HLA; Measles peptides

Indexed keywords

ALANYLSERYLASPARTYLVALYLGLUTAMINYLTHREONYLALANYLGLUTAMINYLGLYCYLGLYCYL GLUTAMINYLISOLEUCYLHISTIDYLGLUTAMINYLLEUCYLLEUCYLARGINYLLEUCYLGLUTAMINE; CYTOKINE; GAMMA INTERFERON; HLA DP ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 4; MEASLES MUMPS RUBELLA VACCINE; MEASLES NUCLEOPROTEIN; MEASLES PHOSPHOPROTEIN; PEPTIDE DERIVATIVE; SERYLALANYLGLYCYLLYSYLVALYLSERYLSERYLTHREONYLLEUCYLALANYLSERYLGLUTAMINYL LEUCYLGLYCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOLESCENT; ADULT; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MEASLES; MEASLES VIRUS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ADOLESCENT; ALLELES; AMINO ACID SEQUENCE; CHILD; CYTOKINES; FEMALE; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMORPHISM, GENETIC;

EID: 33744532752     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.034     Document Type: Article

References (25)

1. Eckels D.D., Lake P., Lamb J.R., et al. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones. Nature 301 5902 (1983) 716-718
2. Germain R.N. Modern concepts in immune recognition and lymphocyte activation: relevance for the development of useful vaccines. Int J Technol Assess Health Care 10 (1994) 81-92
3. Germain R.N. The biochemistry and cell biology of antigen presentation by MHC Class I and Class II Molecules. Ann NY Acad Sci 754 (1998) 114-125
4. Ovsyannikova I.G., Johnson K.L., Muddiman D.C., Vierkant R.A., and Poland G.A. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. J Virol 78 1 (2004) 42-51
5. Eckels D.D., Zeevi A., Beatty P.G., et al. ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC molecules. Hum Immunol 15 1 (1986) 68-74
6. Mellins E., Woelfel M., and Pious D. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis. Hum Immunol 18 3 (1987) 211-223
7. Guttinger M., Romagnoli P., Vandel L., et al. HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Int Immunol 3 9 (1991) 899-906
8. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65 (2004) 1506-1515
9. Ovsyannikova I.G., Johnson K.L., Naylor S., Muddiman D.C., and Poland G.A. Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood. Virology 312 2 (2003) 495-506
10. Dhiman N., Ovsyannikova I.G., Howe R.C., Ryan J.E., Jacobson R.M., and Poland G.A. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods 287 1-2 (2004) 217-225
11. Lewontin R.C. The interaction of selection and linkage. II. Optimum models. Genetics 50 (1964) 757-782
12. Griffin D.E., and Ward B.J. Differential CD4 T cell activation in measles. J Infect Dis 168 2 (1993) 275-281
13. Ward B.J., and Griffin D.E. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 67 (1993) 171-177
14. Panina-Bordignon P., Tan A., Termijtelen A.A.M., Demotz S., Corradin G., and Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 79 (1989) 2237-2242
15. Partidos C.D., and Steward M.W. Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol 71 (1990) 2099-2105
16. Sette A., Vitiello A., Farness P., et al. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. J Immunol 147 11 (1991) 3893-3900
17. Taneja V., and David C.S. HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 101 (1998) 921-926
18. Ovsyannikova I.G., Dhiman N., Jacobson R.M., Vierkant R.A., and Poland G.A. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diag Lab Immunol 10 3 (2003) 411-416
19. Sierpe EAG, Keller E, Bettinotti MDLP, et al., Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press; 1992; W3.7, Oligotyping with DRB generic amplified DNA and oligonucleotides 0-25. p. 454-7.
20. Heward J., and Gough S.C. Genetic susceptibility to the development of autoimmune disease. Clin. Sci. (Lond) 93 6 (1997) 479-491
21. Kappes D., and Strominger J.L. Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem 57 (1988) 991-1028
22. Thorsby E., Berle E., and Nousiainen H. HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev 66 (1982) 39-56
23. Hickman C.J., Khan A.S., Rota P.A., and Bellini W.J. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology 235 (1997) 386-397
24. Demotz S., Ammerlaan W., Fournier P., Muller C.P., and Barbey C. Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment. Clin Exp Immunol 114 (1998) 228-235
25. Phelan D.M., Ovsyannikova I.G., and Poland G.A. HLA-DR/DQ specific monoclonal antibodies block lympholiferative response to measles vaccine in vitro. Mol Aspects Viral Immun 222 (2001) 64 [abstract]